Dashboard
Manage Tickers

ADMSAdamas Pharmaceuticals Inc

Nasdaq www.adamaspharma.com


$ 8.22 $ 0.06 (0.74 %)    

Tuesday, 23-Nov-2021 15:59:50 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 8.22
$ 8.21 x 100
$ 8.23 x 300
-- - --
$ 4.02 - $ 9.15
3,151,400
na
374.98M
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2021 09-30-2021 10-Q
2 08-09-2021 06-30-2021 10-Q
3 05-10-2021 03-31-2021 10-Q
4 02-23-2021 12-31-2020 10-K
5 11-05-2020 09-30-2020 10-Q
6 08-06-2020 06-30-2020 10-Q
7 05-07-2020 03-31-2020 10-Q
8 02-25-2020 12-31-2019 10-K
9 11-07-2019 09-30-2019 10-Q
10 08-08-2019 06-30-2019 10-Q
11 05-09-2019 03-31-2019 10-Q
12 03-04-2019 12-31-2018 10-K
13 11-01-2018 09-30-2018 10-Q
14 08-02-2018 06-30-2018 10-Q
15 05-03-2018 03-31-2018 10-Q
16 02-22-2018 12-31-2017 10-K
17 11-02-2017 09-30-2017 10-Q
18 08-08-2017 06-30-2017 10-Q
19 05-09-2017 03-31-2017 10-Q
20 02-28-2017 12-31-2016 10-K
21 11-03-2016 09-30-2016 10-Q
22 08-04-2016 06-30-2016 10-Q
23 05-10-2016 03-31-2016 10-Q
24 02-23-2016 12-31-2015 10-K
25 11-12-2015 09-30-2015 10-Q
26 08-11-2015 06-30-2015 10-Q
27 05-13-2015 03-31-2015 10-Q
28 03-03-2015 12-31-2014 10-K
29 11-04-2014 09-30-2014 10-Q
30 08-07-2014 06-30-2014 10-Q
31 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benzingas-top-ratings-upgrades-downgrades-for-november-17-2021
Benzinga's Top Ratings Upgrades, Downgrade...
11/17/2021 15:03:23

 

northland-capital-markets-downgrades-adamas-pharmaceuticals-to-market-perform-announces-85-price-target
Northland Capital Markets Downgrades Adama...
11/17/2021 12:41:45

Northland Capital Markets analyst Carl Byrnes downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perf...

adamis-pharmaceuticals-shares-move-higher-traders-circulate-event-page-for-virginiabio-bz-note-co-to-present-wednesday-nov-17
Adamis Pharmaceuticals Shares Move Higher;...
11/16/2021 19:33:25

https://www.vabio.org/event/use-of-tempol-as-an-antiviral-therapeutic-against-covid-19/

adamas-pharmaceuticals-shares-move-higher-magnetar-financial-reports-in-13d-filing-a-685-stake-in-co
Adamas Pharmaceuticals Shares Move Higher;...
10/19/2021 20:29:48

-SEC Filing

benzingas-top-ratings-upgrades-downgrades-for-october-12-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/12/2021 14:48:07

Upgrades

jmp-securities-downgrades-adamas-pharmaceuticals-to-market-perform
JMP Securities Downgrades Adamas Pharmaceu...
10/12/2021 10:52:42

JMP Securities analyst Jason Butler downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Market Outperform to Market Perform.

piper-sandler-downgrades-adamas-pharmaceuticals-to-neutral-raises-price-target-to-8
Piper Sandler Downgrades Adamas Pharmaceut...
10/12/2021 10:48:41

Piper Sandler analyst David Amsellem downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Overweight to Neutral and raises t...

hc-wainwright--co-downgrades-adamas-pharmaceuticals-to-neutral-lowers-price-target-to-91
HC Wainwright & Co. Downgrades Adamas Phar...
10/12/2021 10:40:13

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Buy to Neutral and l...

46-biggest-movers-from-yesterday
46 Biggest Movers From Yesterday
10/12/2021 09:01:23

Gainers

Core News & Articles
Mid-Afternoon Market Update: Dow Tumbles O...
10/11/2021 19:17:03

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
10/11/2021 17:21:26

 

Core News & Articles
Mid-Day Market Update: Crude Oil Surges Ov...
10/11/2021 16:13:16

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also ...

Core News & Articles
28 Stocks Moving In Monday's Mid-Day Session
10/11/2021 16:04:57

Gainers

william-blair-downgrades-adamas-pharmaceuticals-to-market-perform
William Blair Downgrades Adamas Pharmaceut...
10/11/2021 15:44:16

William Blair analyst Tim Lugo downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perform.

supernus-bolsters-parkinsons-portfolio-with-450m-adamas-buyout-highlights
Supernus Bolsters Parkinson's Portfolio Wi...
10/11/2021 12:53:24

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
10/11/2021 12:12:37

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market sessio...

Core News & Articles
Supernus Pharmaceuticals To Acquire Adamas...
10/11/2021 10:31:59

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), today announced a definitive agree...

adamas-announces-gocovri-presentations-at-upcoming-international-parkinson-and-movement-disorder-societys-congress-sept-17-22
Adamas Announces GOCOVRI Presentations At ...
09/16/2021 13:19:54

looking-into-adamas-pharmaceuticalss-return-on-capital-employed
Looking Into Adamas Pharmaceuticals's Retu...
09/10/2021 15:53:17

According to data from Benzinga Pro, during Q2, Adamas Pharmaceuticals's (NASDAQ:ADMS) reported sales totaled $21.97 millio...

adamas-pharmaceuticals-q2-eps-027-beats-029-estimate-sales-2200m-beat-2195m-estimate
Adamas Pharmaceuticals Q2 EPS $(0.27) Beat...
08/09/2021 20:14:16

Adamas Pharmaceuticals (NASDAQ:ADMS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION